Hester Biosciences Limited (NSE:HESTERBIO)

Hester Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	59.65	127.48	131.56	247.5	212.69
Short-Term Investments	-	12.54	25.56	16.61	4.53	-
Cash & Short-Term Investments	72.19	72.19	153.04	148.17	252.03	212.69
Cash Growth	-52.83%	-52.83%	3.29%	-41.21%	18.50%	-9.61%
Accounts Receivable	-	731.81	786.45	796.31	552.8	492.12
Other Receivables	-	69.08	57.85	59.97	17.63	2.39
Receivables	-	858.45	902.86	916.18	631.23	551.5
Inventory	-	703.77	755.81	848.1	753.82	622.22
Prepaid Expenses	-	16.8	12.72	12.83	23.9	9.88
Other Current Assets	-	300.53	321.72	350.64	286.65	218.76
Total Current Assets	-	1,952	2,146	2,276	1,948	1,615
Property, Plant & Equipment	-	4,094	4,076	4,050	3,170	2,411
Long-Term Investments	-	356.65	306.64	267.31	241	27.96
Other Intangible Assets	-	66.57	39.32	29.36	20.44	8.52
Other Long-Term Assets	-	65.36	55.53	76.68	242.17	48.16
Total Assets	-	6,534	6,623	6,700	5,622	4,110
Accounts Payable	-	294.19	258.56	299.77	180.18	280.86
Accrued Expenses	-	26.81	21.37	29.65	16.27	30.59
Short-Term Debt	-	295.79	313.51	588.58	348.45	32.79
Current Portion of Long-Term Debt	-	551.89	389.24	243.17	230.65	182.87
Current Portion of Leases	-	-	0.42	5	4.44	4.24
Current Income Taxes Payable	-	40.17	24.56	33.95	9.38	30.83
Current Unearned Revenue	-	5.04	5.04	12.73	-	35.28
Other Current Liabilities	-	37.95	42.02	274.11	179.6	16.2
Total Current Liabilities	-	1,252	1,055	1,487	968.97	613.66
Long-Term Debt	-	1,334	1,820	1,848	1,644	825.03
Long-Term Leases	-	54.75	53.78	56.69	54.4	55.23
Long-Term Unearned Revenue	-	540.16	543.81	329.64	202.74	184.23
Long-Term Deferred Tax Liabilities	-	59.33	74.11	73.51	65.1	72.76
Other Long-Term Liabilities	-	23.79	45.22	17.16	10.38	-
Total Liabilities	-	3,267	3,595	3,814	2,948	1,751
Common Stock	-	85.07	85.07	85.07	85.07	85.07
Additional Paid-In Capital	-	175.07	175.07	175.07	175.07	175.07
Retained Earnings	-	2,763	2,543	2,423	2,240	1,933
Comprehensive Income & Other	-	119.29	114.64	114.48	99.33	89.55
Total Common Equity	3,143	3,143	2,918	2,797	2,600	2,283
Minority Interest	-	124.01	110.82	88.16	74.09	76.5
Shareholders' Equity	3,267	3,267	3,029	2,885	2,674	2,360
Total Liabilities & Equity	-	6,534	6,623	6,700	5,622	4,110
Total Debt	2,236	2,236	2,577	2,742	2,282	1,100
Net Cash (Debt)	-2,164	-2,164	-2,424	-2,593	-2,030	-887.47
Net Cash Per Share	-247.91	-254.37	-284.99	-304.85	-238.59	-104.32
Filing Date Shares Outstanding	8.09	8.51	8.51	8.51	8.51	8.51
Total Common Shares Outstanding	8.09	8.51	8.51	8.51	8.51	8.51
Working Capital	-	699.9	1,091	788.96	978.66	1,001
Book Value Per Share	369.41	369.41	343.01	328.83	305.62	268.38
Tangible Book Value	3,076	3,076	2,879	2,768	2,579	2,275
Tangible Book Value Per Share	361.59	361.59	338.39	325.38	303.22	267.38
Land	-	136.36	136.36	136.36	102.62	102.62
Buildings	-	1,552	1,554	1,594	1,396	840.99
Machinery	-	2,141	2,053	2,059	1,921	1,267
Construction In Progress	-	1,767	1,681	1,461	802.24	1,087

Source: S&P Global Market Intelligence. Standard template. Financial Sources.